MENVEO
MENVEO
Approved
DIN Number
02347393
Drug Class
Human
Market Date
Jul 29, 2010
Company
HC
GlaxoSmithKline Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02347393
AIG Number0552705002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
J07AH08 MENINGOCOCCUS, A, C, Y, W-135, TETRAVAL. PURIFIED POLYSACC. ANTIGEN CONJUGATED
Product Specifications
Dosage FormSolution
,
Powder For Solution
Route of AdministrationIntramuscular
AHFS Classification80:12.00
Health Canada Classification
ACTIVE INGREDIENTS (5)
CORYNEBACTERIUM DIPHTHERIAE CRM-197 PROTEINActive
Strength: 47 MCG / 0.5 ML
Monograph: CORYNEBACTERIUM DIPHTHERIAE CRM-197 PROTEIN
MENINGOCOCCAL GROUP A OLIGOSACCHARIDEActive
Strength: 10 MCG / 0.5 ML
Monograph: MENINGOCOCCAL GROUP A OLIGOSACCHARIDE
MENINGOCOCCAL GROUP C OLIGOSACCHARIDEActive
Strength: 5 MCG / 0.5 ML
Monograph: MENINGOCOCCAL GROUP C OLIGOSACCHARIDE
MENINGOCOCCAL GROUP W-135 OLIGOSACCHARIDEActive
Strength: 5 MCG / 0.5 ML
Monograph: MENINGOCOCCAL GROUP W-135 OLIGOSACCHARIDE
MENINGOCOCCAL GROUP Y OLIGOSACCHARIDEActive
Strength: 5 MCG / 0.5 ML
Monograph: MENINGOCOCCAL GROUP Y OLIGOSACCHARIDE